Management of Leucopenia in Dengue Fever

Monitoring and Assessment

• Daily complete blood count monitoring is essential for tracking both white blood cell and platelet counts in dengue patients, according to Praxis Medical Insights 1
• Warning signs of progression to severe disease include high hematocrit with rapidly falling platelet count, severe abdominal pain, persistent vomiting, lethargy or restlessness, and mucosal bleeding, as recommended by Praxis Medical Insights 1

Management Approach

• Symptomatic management is the cornerstone of treatment for dengue with leucopenia, as there is no specific antiviral therapy currently approved, according to Praxis Medical Insights 1
• Avoid aspirin and other non-steroidal anti-inflammatory drugs due to increased bleeding risk, as recommended by Praxis Medical Insights 1
• Use acetaminophen/paracetamol for fever management, according to Praxis Medical Insights 1

Fluid Management

• For patients without signs of shock, encourage oral hydration with fluids containing electrolytes and monitor urine output to ensure adequate hydration, as recommended by Praxis Medical Insights 1
• For patients with signs of shock, administer an initial fluid bolus of 20 mL/kg with careful reassessment afterward, according to Praxis Medical Insights 1

Specific Management for Leucopenia

• No specific treatment is required for the leucopenia itself unless there are signs of secondary bacterial infection, as recommended by Praxis Medical Insights 1
• If secondary bacterial infection is suspected, consider empiric antibiotics only if clear evidence of bacterial infection exists, according to Intensive Care Medicine 2

Monitoring for Complications

• Monitor for signs of adequate tissue perfusion, including normal capillary refill time, absence of skin mottling, warm and dry extremities, well-felt peripheral pulses, normal mental status, and adequate urine output, as recommended by Praxis Medical Insights 1

Prevention of Complications

• Avoid excessive fluid boluses in patients without shock to prevent fluid overload and respiratory complications, according to Praxis Medical Insights 1
• Recognize the critical phase (typically days 3-7 of illness) when plasma leakage can rapidly progress to shock, as recommended by Praxis Medical Insights 1

Special Considerations

• Higher risk populations requiring closer monitoring include infants and elderly, according to Intensive Care Medicine 2

Common Pitfalls to Avoid

• Failing to recognize the critical phase when complications are most likely to occur, as warned by Praxis Medical Insights 1
• Administering NSAIDs which can worsen bleeding tendencies, according to Praxis Medical Insights 1
• Delaying fluid resuscitation in patients who develop dengue shock syndrome, as cautioned by Praxis Medical Insights 1
• Inadequate monitoring during the critical phase of illness, according to Praxis Medical Insights 1